Source: GlobeNewswire

Press Release: Larkspur Biosciences : Larkspur Biosciences to Participate in the 2023 BIO International Convention

WATERTOWN, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a biotechnology company building the next precision immunotherapies to outsmart cancer, announced that they will be participating in the 2023 BIO International Convention being held June 5-8 at the Boston Convention & Exhibit Center, Boston, MA.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Catherine Sabatos-Peyton's photo - CEO of Larkspur Biosciences

CEO

Catherine Sabatos-Peyton

CEO Approval Rating

90/100

Read more